Puretech Health (PRTC) Given Buy Rating at Numis Securities

Numis Securities reiterated their buy rating on shares of Puretech Health (LON:PRTC) in a research note published on Monday morning. The firm currently has a GBX 259 ($3.64) target price on the stock.

PRTC has been the subject of several other reports. Liberum Capital reiterated a buy rating and set a GBX 248 ($3.48) price target on shares of Puretech Health in a report on Thursday, November 30th. Peel Hunt reiterated a buy rating and set a GBX 302 ($4.24) price target on shares of Puretech Health in a report on Tuesday, January 2nd. N+1 Singer reiterated a buy rating on shares of Puretech Health in a report on Thursday, November 30th. Finally, Jefferies Group reiterated a buy rating on shares of Puretech Health in a report on Friday, November 17th. Five investment analysts have rated the stock with a buy rating, The stock currently has an average rating of Buy and a consensus target price of GBX 260.20 ($3.65).

Puretech Health (PRTC) opened at GBX 181.70 ($2.55) on Monday. Puretech Health has a 52 week low of GBX 110 ($1.54) and a 52 week high of GBX 183.50 ($2.58). The firm has a market capitalization of $423.98 and a P/E ratio of -1,009.44.

COPYRIGHT VIOLATION NOTICE: “Puretech Health (PRTC) Given Buy Rating at Numis Securities” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/02/puretech-health-prtc-given-buy-rating-at-numis-securities.html.

Puretech Health Company Profile

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.

Analyst Recommendations for Puretech Health (LON:PRTC)

Receive News & Ratings for Puretech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puretech Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply